Induction of apoptosis of bladder cancer cells by zinc-citrate compound

Korean Journal of Urology

Volumn 53, Issue 11, 2012, Pages 800-806

  Hong, Sung Hoo ^a   Choi, Yong Sun ^a   Cho, Hyuk Jin ^a   Lee, Ji Youl ^a   Hwang, Tae Kon ^a   Kim, Sae Woong ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Apoptosis; Urinary bladder neoplasms

Indexed keywords

ACONITATE HYDRATASE; CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; ZINC CITRATE; ZINC ION;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; DNA DETERMINATION; DOWN REGULATION; ENZYME ACTIVATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 84869792899     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2012.53.11.800     Document Type: Article

References (30)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Heney NM. Natural history of superficial bladder cancer. Prognostic features and long-term disease course. Urol Clin North Am 1992;19:429-33.
3. Lutzeyer W, Rubben H, Dahm H. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 1982; 127:250-2.
4. Powell SR. The antioxidant properties of zinc. J Nutr 2000;130(5S Suppl):1447S-54S.
5. Truong-Tran AQ, Carter J, Ruffin RE, Zalewski PD. The role of zinc in caspase activation and apoptotic cell death. Biometals 2001;14:315-30.
6. Bae SN, Lee YS, Kim MY, Kim JD, Park LO. Antiproliferative and apoptotic effects of zinc-citrate compound (CIZAR(R) on human epithelial ovarian cancer cell line, OVCAR-3. Gynecol Oncol 2006;103:127-36.
7. Bae SN, Kim J, Lee YS, Kim JD, Kim MY, Park LO. Cytotoxic effect of zinc-citrate compound on choriocarcinoma cell lines. Placenta 2007;28:22-30.
8. Costello LC, Feng P, Milon B, Tan M, Franklin RB. Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis 2004;7:111-7.
9. Pabon ML, Lonnerdal B. Effect of citrate on zinc bioavailability from milk, milk fractions and infant formulas. Nutr Res 1993;13:103-11.
10. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, et al. Superficial bladder cancer: progression and recurrence. J Urol 1983;130:1083-6.
11. Nseyo UO, Lamm DL. Immunotherapy of bladder cancer. Semin Surg Oncol 1997;13:342-9.
12. Nadler RB, Catalona WJ, Hudson MA, Ratliff TL. Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapy. J Urol 1994;152(2 Pt 1):367-73.
13. Herr HW. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J Urol 2000;163:60-1.
14. Ho E. Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem 2004;15:572-8.
15. Prasad AS, Kucuk O. Zinc in cancer prevention. Cancer Metastasis Rev 2002;21:291-5.
16. Wellinghausen N, Kirchner H, Rink L. The immunobiology of zinc. Immunol Today 1997;18:519-21.
17. Singh KP, Zaidi SI, Raisuddin S, Saxena AK, Murthy RC, Ray PK. Effect of zinc on immune functions and host resistance against infection and tumor challenge. Immunopharmacol Immunotoxicol 1992;14:813-40.
18. Zowczak M, Iskra M, Torlinski L, Cofta S. Analysis of serum copper and zinc concentrations in cancer patients. Biol Trace Elem Res 2001;82:1-8.
19. Wu T, Sempos CT, Freudenheim JL, Muti P, Smit E. Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann Epidemiol 2004;14:195-201.
20. Provinciali M, Di Stefano G, Fabris N. Dose-dependent opposite effect of zinc on apoptosis in mouse thymocytes. Int J Immunopharmacol 1995;17:735-44.
21. Schrantz N, Auffredou MT, Bourgeade MF, Besnault L, Leca G, Vazquez A. Zinc-mediated regulation of caspases activity: dose-dependent inhibition or activation of caspase-3 in the human Burkitt lymphoma B cells (Ramos). Cell Death Differ 2001;8:152-61.
22. Fong LY, Lau KM, Huebner K, Magee PN. Induction of esophageal tumors in zinc-deficient rats by single low doses of N-nitrosomethylbenzylamine (NMBA): analysis of cell proliferation, and mutations in H-ras and p53 genes. Carcinogenesis 1997;18: 1477-84.
23. Epner DE, Herschman HR. Heavy metals induce expression of the TPA-inducible sequence (TIS) genes. J Cell Physiol 1991; 148:68-74.
24. Givol I, Givol D, Hughes SH. Overexpression of p21waf1/cip1 arrests the growth of chicken embryo fibroblasts that overexpress E2F1. Oncogene 1998;16:3115-22.
25. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
26. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366:701-4.
27. Kondoh M, Tasaki E, Araragi S, Takiguchi M, Higashimoto M, Watanabe Y, et al. Requirement of caspase and p38MAPK activation in zinc-induced apoptosis in human leukemia HL-60 cells. Eur J Biochem 2002;269:6204-11.
28. Fong LY, Nguyen VT, Farber JL. Esophageal cancer prevention in zinc-deficient rats: rapid induction of apoptosis by replenishing zinc. J Natl Cancer Inst 2001;93:1525-33.
29. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-6.
30. Kim BH, Kim CI, Chang HS, Choe MS, Jung HR, Kim DY, et al. Cyclooxygenase-2 overexpression in chronic inflammation associated with benign prostatic hyperplasia: is it related to apoptosis and angiogenesis of prostate cancer? Korean J Urol 2011;52: 253-9.